MH<l>OPMAI.JJHI 3A IBIIbJIHEHMETO HA,a:orOBOP 3A OEI..QECTBEHA IIOPbqKA. <l>akc

Size: px
Start display at page:

Download "MH<l>OPMAI.JJHI 3A IBIIbJIHEHMETO HA,a:orOBOP 3A OEI..QECTBEHA IIOPbqKA. <l>akc"

Transcription

1 /1-11 #cf H P/72..,.?7 e, napnu1a: h/7 - '753 7 ~. HH<l>OPMAUW! 3A H3nl,J1HEHJ1ETO HA /lofobop 3A 06ll!ECTBEHA D0Pb4J<A (eepcu, 4),J <r ~ Aon '- ArEHL.1lt15l no 06L1.1ECTBEHlt1 nopb YKltl 1000 Cocj)H~, yn. nere 4 cj)akc: rop@aop.bg, e-rop@aop.bg HHTepHeT a}lpec: MH<l>OPMAI.JJHI 3A IBIIbJIHEHMETO HA,a:orOBOP 3A OEI..QECTBEHA IIOPbqKA.LJ:EJI O BO.LJ:HA IIH <l>o PMAll;IUI )];ejioboaha BHIJ>OpMaUUH ITaprn:.ua Ha Bb3JIO)K11Tem1: 0 I 482 IT0.uenem1e: ---~ YbXO.UJ!W HOMep: ~ 1.=--L=t;~' ~lj, OT.uarn.1 ~ (0. '2& J_{) KoMeHTap Ha Bb3JIO)Kl1Tem1 : PA3.LJ:EJI I: Bb3JIO)KlfTEJI ~no 4JI. 7, T. 1-4 OT 30IT (KJTaC114eCK11) Ono 4JI. 7, T. 5 HJIH 6 OT 30IT (cektopeh) 1.1) HamuenoBanue n ai:.pec Ocp11u11anHo Ha11MeH0Bam1e l1h CTv! TYT no Mv!Kp06v!OJ10 I' v!.r,,cteq>ah AHI' e JlOB " A.upec yjj. AKa.IJ;. reoprvr 50H4e B, 6J1. N' 26 fpa.u IToweHcK11 KO.U I )];bp)kaba Coqivr.R 1113 E'bn rapvr.r 3a KOHTaKTl1 Tenecpott l1hctv!tyt no Mv!Kp06v!OJ10 I' v!.r ; ,, CT e q>a H AHr e JJOB " J111ue 3a KOHTaKT.nou.. Ma prapvrta KaM6ypoBa,.nou.. AH a CTac Ti a IIJO B EneKTpOttHa nowa I1HTepHeT a.upec/ 11 (KOraTO e np11jio)kl1mo) A.upec Ha B'h3JIO)Ki1Ten J1: http : //www. mi crobi o. bas. bg/. <l>akc A.upec Ha npocp11na Ha KynyBaYa : http : //www. mi crobio. bas. bg / I MB%20web%20page/microbi o/zop % 20. html. 1.2) Bui:. ua Bb3JI O:>KUTeJIH " OCHOBHa i:.eiiuoct/u: (nonbnba ce OT Bb3JI O)K11Ten 11 no 4JI.7, T.1-4 OT 30I1) O M11H11cTepcrno 11n 11.upyr.Ubp)KaBeH oprah, 0 06wecrneH11 y cnyrn BKJ1I0411TeJIHO TeXHl1 per110haji Hl1 11Jl11 0 0T6paHa MeCTHH no.npa.3.nen eh1151 D 0 6w ecrneh pe.u 11 chryphoct O Hau110HanHa arem.(1151/cjiy)k6a OOKOJIHa cpe.ua O PernomllleH HJIM MecTeH oprah 0 I1KOH0Ml14eCKa 11 cp11ttattc0ba.uett HOCT O PernoHanHa MJIH MeCTtta arehuhj1/cny)k6a D 3.upaBeona3BaHe ~ ITy6n11YHonpasHa oprah11jauhj1 D HacrnmrnaHe/)KMJIHWHO CTp0 11Ten ctbo 11 O EBponettcKa 11HCTMTyuwr/arettUttJ1 11JIM MeCTa 3a OT,lll1X M KYJITypa Me)K.L\yHapo.uHa oprattl13auwr O Cou11anHa 3aKpmrn YHD: aeeaobjf. Jecb-4 JcO-b I f9-5se3b60b65a I

2 n apt1t.aa: HH<l>OPM AUW! 3A J,fJITT,JlHEHJ1ETO HA norosop 3A 06UIECTBEHA nopb4l<a (oepc11 4) 0.IJ:pyro (MOJUI, YT04HeTe): Tn11x, KY mypa 11 pe1mrm1 006pa30Bam1e 1:81.IJ:pyro (MOJI51, yto rnete): Hay<-rna.[\eHHOCT 1.3) OcuoBua AeiiuoCT/u ua Bb3JI0:1KUTe J1H, CBbp3aua/u c: (non'hnba ce OT Bb3JIO)Kl1Ten no 'IJI. 7, T.5 11n11 6 OT 30IT) OITpo113aoncrno, npettoc 11 pa:mpe.ne11ett11e tta OrromettcKM ycnyrn np11po.nett ra:3 11 Tonn11tttta etteprm1 D EneKTp11tiecKa etteprn.51 0)Kene3onbTHl1 ycnyrn 0Tbpcette, npoyqaatte 11n11 li0611b Ha Orpal!CKl1 )KeJie30TibTHl1, TpaMBaHHl1, np11ponett ra:3 11n11 tteqn Tponeti6yctt abt06yctt11 ycnyrn 0 Tbpcette, npoyqaatte m111.no611b Ha OITp11crntt11mtt11 netittoct11 B'hrn11ma 11n11 npyrn rnopn11 rop11ba 0Bona 0 Jiernll.(Hl1,ll,eHHOCTl1 PA3,IJ:EJI II: IlPOI(E,IJ:YPA, IlPE,IJ:XO)K)J:All(A CKJII01IBAHETO HA,IJ:OrOBOPA 11.1) Bull ea npouellyparn i:8iotkp11rn npou:enypa D Orpatt11tietta npou:e.l\ypa D CocTe3aTeJieH n11anor 0.IJ:oroaap51tte c o65ibj1ett11e 0.IJ:oroaap51He 6e3 o65ibj1ett11e 11.2) 06eKT Ha nopb'ikarn D CTpo11Tencrno 1:81.IJ:ocrnBK ) Ilpouellyparn e OTKpnTa c perneuue No: 55 OT 13 /01/2016 MiMM/rrrr 0Ycnyrn 11.4) YHHKaJleH }(Qua nopb'ikata B PenICTbpa Ha 060.-ecTBeHHTe nopb'ikh (nnnnn-yyyy-xxxx) II.5) Onucaeue ea npellmeta ea nopb'ikata UenTa Ha HacToRmaTa oomectbeha nopbyka e na ce M36epaT M3T1bJlHMT 8 JlM, KOMTO na noctabrt MaTepMaJIM, XMMMKaJIM M KOHCyMaTMBM 3a Ha yyho - M3 CJie.[(OBaT e JICKM npoektm B M3TibJIHeHMe Ha lloi'obop N! ll03-100/ I'. 3a M3T1bJIH e HMe Ha npoekt : " Pa3H006pa3Me M 6MOTeXHOJlO I'MYeH notehumaji Ha Archaea OT 6bJII'apCKM ropemm M3BOpM " M lloi'obop N! ll / I'. 3a M3T1bJIHeHM e Ha npoekt : AHaJIM3 Ha ahtmtrjiobmr peneptoap C TIOMOmTa Ha paumohajiho non6pahm nentmllhm MaCMBM ", q)mhahcmpahm no MRpKa " ITpoeKTM 3a Me~lIYMHCTMTYUMOHaJIHO CbTpy nhmyectb0 11 OT EBponeMCKOTO MKOHOMMYeCKO npoctpahctbo , nporpama BG09 " <DOHlI 3a CTMneHllMM Ha EMIT ". C M3T1bJIHeHMeTO Ha npo e KT " Pa3H006pa3Me M 6MOTeXHOJIOI'MYeH notehumaji Ha Arch aea OT 6bJII'apCKM ropemm M3BOpM " ce uenm orro3habahe apxeanhoto pa3hoo6pa3me B 6bnrapcKM ropemm M3BOpM M M30JIMpaHeTO Ha HOBM e KCTpeMOq)MJIHM apxem, npenn aramm HOBM 6MOTeXHOJlOI'MYHM Bb3MO~HOCTM. C MOJieKyJIRpH0-6MOJIOI'MYeH no.nxo.n me c e xapaktepm3mpa ctpyktypata Ha apxeanhmte Cbo6mecTBa, me ce onpe nejirt liommhahthmte M MMHOpHO npe.nctabehm TaKCOHM. me ce M30JIMpaT KYJITMBMpyeMM apxem Mme ce ontmmm3mpat ycjiobmrta 3a TRXHOTO KYJITM BMpaHe. Cpen M30JiaTMTe me ce TbpCRT HOBM 6MOJ10I'MYHM BMllOBe. me ce cekbehmpat M ahajim3mpat rehommte Ha M36paHM M30JlaTM Cuen na ce yctahobm npmcbctbmeto Ha rehm, KOnMpamM HOBM eh3mmm M nojim3axapmnm. qpe3 CKpMHMHI' me ObllaT rron6pahm rrepcrrektm BH M nponyuehtm Ha Te3M 6MOTeXHOJIOrMYHO u ehhm semectba. UenTa Ha npoekt uahajim3 Ha ahtmtrjlobmr peneptoap C TIOMOmTa Ha YHll: aeeaoblf-1 ecb-41 co-b I f9-55elb60b65a I

3 napnrna: O H<l>OPMAUW! 3A H3ffb1IHEHHETO HA,!IOrQBOP 3A 051.IlECTBEHA flopbl[j{a (sepc11, 4) pal..lj,10hanho no,ll6pahi1 nent!1,llhj1 MaCMBM II e,ila ce C'b3,lla,lle HO Ba nnatwopma 3a,ll MarHOCTMKa, OCH OBaHa Ha ahanv13 Ha peneptoapa OT ahtmtena (v1nv1 MrOMa ) y OT,lleneH MH,llv1BM,ll C CTOMOmTa Ha 6v16nv10TeKa OT MM06!1flv13MpaHM nentm,llm (rnicroarray ). AHTMTenaTa pa3ct03habat cneumw!14ho BacT OT MoneKynaTa Ha C'bOTBeTeH ahtmreh HapeBeHa enj1ton. TienT!1,lll1Te, KaTo 4aCTM OT npotemhobj1 MOfleKynv1, npeactabnrbat notehuv1anhv1 env1tonv1, HO no - 4ecTo ce pa3n03habat Kp'bCTOCaHO OT aht!1tena C,llpyra cneumwm4hoct ( KopeKTHO e )lace r0bopv1 3a nonv1cneuv1~m4hoct ). ToraBa Te3v1 nentmlll1 ce Hapv1YaT MMMOTOCTM. Tipe,llno~eHMTe nentm,llhm 6v16nv10TeKv1, B T03M CMMC'bn, ca 6v16nv10TeKM OT MMMOTOnM, KOMnneMeHTapHM M OCTTMManHO npe,llctabrmm pa3h006pa3meto OT cneum~m4hoctm Ha ahtmtena B peneptoapa. Cne)lOBaTenHo, TOBa me 6'b)le Ha6o p OT nentm,llm (nx103 ) B'bB ~OpMaT Ha rnicroarray, KOMTO ewektmbho OTBMTa,llMHaMMKaTa Ha C'bBKYDHOCTTa OT ahtmtena npv1 nmnca Ha MH~OpMaUJ1R 3a npv1po,llata Ha ahtmrehmte np0b0kv1panv1 npomehmte. PenepToap'bT Ha Mrr M MrM ahtmtenata me 6'b)le!13Cfle,llBaH l1h,lll1bl1llyanho l1 Ha nonynaumohho Hl1BO. 3a o6o6mehata KapTMHa me M3non3BaMe MMyHorno6ynMHOBM npenapatm 3a Be H03HO npmno~ehm, KOMTO ca C'b3,lla,lleHM Ha 6a3aTa Ha c6op OT cepymm Ha Ha,ll llohopm. Tiouo6eH TeCT Ha CMCTeMHO Hl1BO MMa 3HaBv1TeneH notehuv1an 3a npj1no~ehv1e npm,llma r HOCTMKa Ha abtommyhhm, OHKOnOrM4HM, MH~eKUM03HM M Cl1CTeMHM B'b3nanMTenHM 3a6onRBaHMR. Tipe,llMlliHM!13Cne,llBaHMR,llOpM C HeOTITMMM3MpaHM ( cnybamhm ) 6M6flMOTeKM CTO,llCKa3BaT l13heha,llbam Kanauv1TeT 3a e,llhobpemehha,llmarhoctmka He camo Ha pa3nl14hl1 3a6onRBaHMR, HOM, HanpMMep, pa3flv14hl1 CTa,llMM l1 ~opmm Ha TyMOpM. ToBa e B'b3MO~HO 3amoTO BpoueHMRT l1 a)lacttj1bhmrt MMYHMTeT 3ae,llHO C'bCTaBnRBaT ectectbeh ceh3op 3a npomehm B,,MoneKynHMR nem3a~" Ha oprahm3ma, a ahtmtrflobmrt peneptoap e CMrHan Ha M3XO,lla OT Ta3M CMCTeMa, KOMTO TpR6Ba )la 6'b)le OT4eTeH C MHCTpyMeHTMTe Ha CMCTeMHaTa 6 v1o norv1r. ~emhoctmte no M3n'bnHeHMe Ha HaCTORmaTa o6mectbeha nop'b4ka BKfl~4BaT,llOCTaBKa Ha XMMMKanv1, peaktmbm l1 KOHCyMaTMBM, KOMTO )la C'b3,lla,llaT B'b3MO~HOCTM 3a npobe~,llahe Ha Ka4eCTBeHa HayYHO - v13cne,ll0batencka M pa3bomha,llemhoct B MHCTMTYT no M!1Kpo6v1onorv1R,,CTewaH AHrenoB" npv1 BAH. XMMMKanv1Te, peaktmbmte l1 KOHCyMaTMBMTe, KOMTO me 6'b)laT,llOCTaBe HM ca CB'bp3 ahm nprko C,lleMHOCTTa Ha MHCMTMTYT no MMKpo6v1onorv1R,,CTe~aH AHrenoB". PA3,ll;EJI III: YCJIOBIDI HA,n:o r obopa III. I) HoMep Ha L(OroBopa: 13 OT 04/05/2016.llJVMM/rrrr III.2) H a ctosl lll,hsit i:.orobop e CKJI JOtJ eu cjiei:. ~Tipo u el\ypa 3a Bb3naratte Ha o 6 ruecrne Ha n o pb 11Ka O PaMKOBO c n o p a3yme HHe D.nHHaMH 11Ha CHCTeMa 3a L(OCTaBKH 0 CHcTeMa 3a npe1lbap HTe11eH no.[(6op III.3) lljnbji HHTeJI no i:.orobopa O qmu HanHo HaHM e HOBaHHe H EHK (KOL\ n o EyncrnT) PM,llaKOM EOO~ EMK A.npec yn. KonoMaH N! 1 rpa.l\ TiorueHCKJi! KO L( I,nbp )KaBa Co~MR 1618 E'bnrapv1R E nektpotttta rrorua Teneq:iott <DaKC YHfl: aeea0b3f- Jecb-4 Jc0-b J 11/-55e3b60b65a I

4 napnu1a: O 1482 l1h<l>opmaul1r 3A l13it1j!hehl1eto HA /lofobop 3A 06UlECTBEHA nopb'll<a (sepc 11, 4) I1HTepHeT a.npec (URL): I III.4) Ilpu H3DbJIHeuneTo yqactbat no.a:ujnbjihhtejrn,lj;a D He~ O<J!nQnaJiuo uanmeuobaune ua,lj;ehhoct, H3UbJIHHBaua OT,Ll;HJI ua UOtJ;H3UbJIHHTeJIH UO/lH3UbJIHHTem1 yqactne ua IIl.5) IlpellMeT ua noroeopa,[\octa BKa Ha BaHa 3a e nektpo<pope3a. UOllH3UbJIHHTe JIH (% OT.a:oroeopa) 111.6) CpoK ua H3UbJiueune CpoK Ha H3rrb11Hem1e B Meceutt: QHl1 ( OT CKJ110 1 rnahe Ha.norosopa) Ha'1anHa.narn.n.nl MMl rrrr Kpa11Ha.narn 30/09/2016.n.nl MMl rrrr 111.7) CTonuocT, nocoqeua B noroeopa (e Qn<J!pu): CTOttHOCT: 379 Barryrn: BGN Pa3MeHeH Kypc KoM BGN: 111.8),LJ;oroeopbT e <fiuuaucnpau c ebponenckn cpe.a:ctba <l>hhahchpaheto e 100 % OT CTOHHOCTTa Ha.noroaopa. PA3,[(EJI IV: H3IlbJIHEHHE HA,n;orOBOPA ~.norosopot e H3noJTHeH O.norosopoT e npe.ncpo4ho npekpateh IV.I),LJ;arn ua npnkmoqbaue/npekpathbaue: 07 /07/2016.n.nl MMl rrrr 6e3.n:.n:c C LJ:LJ:C CTotiHOCT Ha ~ D np11 IV.2) Ilpnqnun 3a npekpathbaue ua.a:orobopa (KoraTo e nphjiojkhmo) MC(so/o) (KpaTKO om1cahhe Ha o6ct05!tejtctbata, KOHTO o6ycjtab5!t npekpat.si.baheto) IV.3),LJ;oroeopbT e H3MeuHn/.a:onbJIBau,LJ;a D He~ IlpoMeueuo Ilpe.a:n npomhhata CJie)l npomhhata IlpaBHO OCHOBaune ycjiobhe OT.a:oroBopa 3a npomhhata IV.4),LJ;oroBOpbT e H3UbJIHeH B cpok LJ:oroaopoT e 113n1,11HeH c1,c 3a6asa OT Meceu(a) 11JT11..QH11 OT KpattHH51 cpok Ha 113n1,JTHeH11e Ha.noroaopa Dp11411H11 3a 3a6aaarn (KoraTo e nphjl O)KHMO ): (KpaTKO onttcah11e Ha nph4hhhte 3a 3a6asarn) IV.5),LJ;oroeopbT e H3UbJitteu B nbneu o6em J13n1,1rneH11eTo e % OT npenmern Ha noroaopa (np11 'lacth4ho H3noJIHeHtte). Dp11411Hl1 3a 4aCTl1 4HOTO 11301,JlHeHHe (KoraTO e nphjt0)!(11mo): YHTI: aeea0b3f- Jecb-4 lc0-b I f9-55e3b60b65a I

5 n apnu,a: H<!>OPMAU11Jl 3A 113IT1JIHEHMETO HA norosop 3A 061.UECTBEHA nop1,l!ka (sepc11 4) (KpaTKO om1cam1e Ha rrpwihhhte 3a tjactwihoto 113flbJ1HeH11e) IV.6) Mu1J>0pMau:uH Ja HJnJiaTeuarn cyma no ti:orobopa (B u:u<t>pu): I 6e3 )UlC C )U(C CTottHocT Ha )U(C (B %) CTOHHOCT: Barryrn: BGN ~ D rrp 11 Pa3MeHeH Ky pc KbM BG IV.7) BbB Bpb3Ka c H3DbJIHeuueTo na ti:orobopa ce ti:bmkat HJIH ca ajiatenn,ll;a D He~ neyctohkh D OT 113rrbJ1HI1Tem1 Pa3Mep : Banyrn: D OT Bb3J10)l(11Tem1 Pa3Mep : Banyrn: npwrnhh 3a Bb3Hl1KBaHe Ha 3a)lbJl)l(eHHeTO 3a HeycTOHKHTe (KOraTO e rrphjjo)l(hmo) : (KpaTKO orr11catt11e Ha rrpwrnhhte 3a tteyctohkhte) V:,Ll;PYrA MH<l>OPMAU:MJI (i.:orato en HJIO'.IKHMo) VI:,Ll;A TA ua H3D aiu:ane ua uacrns,"'~~t:.:a:...:.:".::".:ip:..::o:..tp:.::m:..:a:..:u::=..u::.r:: ,.lj:arn: 14/ 10/2016 M I MM/rrrr ~...,. BbJJIO'.IKHTeJI : TpHTe HMena: / rro)ln11c 11 netjat/ qn. Kop. XpxcTo Mxna.&i tt~ tj:jib'.ikhoct: )lxpektop 1,a r'i'r.[(ehckm I.[(BMH YI-ITI : aeea0b3f-l ecb-4 lco-bl f9-55e3b60b6sal

HH<l>OPMAUIUI 3A H31TbJIHEHHETO HA,n:orOBOP 3A OEI.IJ:ECTBEHA IIOPbqKA. <l>akc

HH<l>OPMAUIUI 3A H31TbJIHEHHETO HA,n:orOBOP 3A OEI.IJ:ECTBEHA IIOPbqKA. <l>akc _#! # ct U/.../ H Oj'>14'.,- 1.#O/l- ~5o3 ~3 naprnna : 01 482 11HOPMAUW! 3A H3ffiJIHEHHETO HA J:IOrQBOP 3A OoWECTBEHA nop1,ljka (aepc1«4) ~ AO II '- ArEHljl,151 no 0 6ll(ECTBEH1t1 n OPb4 Klt1 1000 CocjJ1.1~,

More information

MH<l>OPMAU:lUI 3A M3II'bJIHEHMETO HA J(OrOBOP 3A OEII(ECTBEHA IIOP'bqKA. <DaKC

MH<l>OPMAU:lUI 3A M3II'bJIHEHMETO HA J(OrOBOP 3A OEII(ECTBEHA IIOP'bqKA. <DaKC n apnu1a: O 1482 AO TI ArEHL.1~51 no 05Ll.lECTBEH~ nopb'-lk~ 1000 Cocj)1,rn, yn, nere 4 cj)akc: 940 7078 e-mail: rop@aop.bg, e-rop@aop.bg ~HTepHeT aapec: http://www,aop.bg MHOPMAU:lUI 3A M3II'bJIHEHMETO

More information

A O I1. ,n; n p:>i<aba Perryom1Ka B'bJirap:v:rR. ,l(eji OBO,l(HA IIH <1>0 PMAU:IIH. PA3,l(EJI 1: Bb3JI0)KIITEJI. 1.1) HauMeuosauue u a.upec.

A O I1. ,n; n p:>i<aba Perryom1Ka B'bJirap:v:rR. ,l(eji OBO,l(HA IIH <1>0 PMAU:IIH. PA3,l(EJI 1: Bb3JI0)KIITEJI. 1.1) HauMeuosauue u a.upec. flaptii.qa: 00353 PElUEHME (sepcu" 4) ~ A O I1 ArEHL\V15l no 06Ll.\ECTBEHV1 nopb4kv1 1000 Co 1-lH, yn. nere 4 cjlakc: 940 7078 e-mail: rop@aop.bg', e-rop@aop.bg 1-lHTepHer aapec: http://www.aop.bg IIpoeKT

More information

I.lhp)Kaea: AOII. ,[(E.JIOBO.lJ;HA HH <l>opmaijjui. Byprac BG BG JIHue aa KOHTaJ<T:

I.lhp)Kaea: AOII. ,[(E.JIOBO.lJ;HA HH <l>opmaijjui. Byprac BG BG JIHue aa KOHTaJ<T: napt11;10. 00301 06!1BJIEHJ.1E JA flpl(kj1l04bahe HA.norOBOP 3A 06[UECTBEHA nop'bl[l(a (8

More information

AOn. DIlpoexr na peinenae ~ Peuienae sa 6J1HK sane PEIDEHIIE. ,lj;ejiobo,lj;hahh ci>opmaqhji

AOn. DIlpoexr na peinenae ~ Peuienae sa 6J1HK sane PEIDEHIIE. ,lj;ejiobo,lj;hahh ci>opmaqhji Flapruna: 00073 PEWEHHE(eepcna 4) ~ AOn ArEHLlItI5I no OEil1.lECTBEHItI nopb4kiti 1000 Ccxt>~SI,yn. Jlere 4

More information

PA3tJ:E.71 I: B'h3JIO)KHTEJI

PA3tJ:E.71 I: B'h3JIO)KHTEJI n apn1..1a Ob}IBJll'HllF "la nol"b4j

More information

P A3}lF..71 I: B1>3.7L\r AIQ OPr AH

P A3}lF..71 I: B1>3.7L\r AIQ OPr AH 06J1BJIEHME 3A nop'b'lka (1cpau 7) IlpHTYl)xa ln>m Oc}>~aJJea eecthhk Ha Eepooeii:CKHJI C'b103 HHq>opMauHJ1 n ohjhlhh q,opm)'jutph: htn>://simap.ted.europa.eu OilpoeKT Ha 06.11BJieHHe ~06.11BJ1eHue 3a

More information

The Effects of Hydrophilic Contact Lens Wear on the Reduction of Progressive Myopia in Adolescents. by Bob Deck

The Effects of Hydrophilic Contact Lens Wear on the Reduction of Progressive Myopia in Adolescents. by Bob Deck The Effects of Hydrophilic Contact Lens Wear on the Reduction of Progressive Myopia in Adolescents by Bob Deck The purpose of this retrospective study was to evaluate the effects of hydrophilic contact

More information

IIPOTOKOJI.N!! 1. Ha a.n;m.f?l>kobo.[(hteji-okpo)j(eh ITpoKypop Ha 0Kpo)J(Ha

IIPOTOKOJI.N!! 1. Ha a.n;m.f?l>kobo.[(hteji-okpo)j(eh ITpoKypop Ha 0Kpo)J(Ha IIPOTOKOJI.N!! 1 OT 3ace.n;amrn Ha KOMHc1u1Ta, Ha3HaqeHa enc 3aIToBe.n; NQ P,[(-04- l 68/24.08.20l5r. Ha A.n;MHHHCTpaTHBHH51 pokobo.[(hteji - okpo)j(eh ITpoKypop Ha 0Kpo)J(Ha ITpoKypaTypa Pyce, 3a co6hpahe,

More information

I Peuieiiie HoMep: P - OT.zaTa: 27/07/2016 WIJMM/rrrr )JEJIOBO)iHA HHOPMAUH5I

I Peuieiiie HoMep: P - OT.zaTa: 27/07/2016 WIJMM/rrrr )JEJIOBO)iHA HHOPMAUH5I I1apT1I'I 00, 4 PF11JF1f14F3A ()Tf1'L1BA14F HA ni'ni IFjVP. (U'pCTI () AEHL4W$1 no OBLI1ECTBEHW flopbykl'l AF 1000 Cocni, yn. Jlere 4 J\ ij H e-mail: pkaop.b, aooaop.bg HHTHT alpec: httd://www.aop.bg E1

More information

1. npe.!vlaram Aa H3nbllHHM nopbykata nplil Clle,QH1!1Te YCllOBVISI:

1. npe.!vlaram Aa H3nbllHHM nopbykata nplil Clle,QH1!1Te YCllOBVISI: AO npeaceaa TEJl.R HA BbPXOBHM.R KACAI.lMOHEH CbA fp.cocpm.r, 6Yn.,BMTOWA" N22 TEXHM4ECKO npeano>kehme 3a npo&~~ypa 3a M36op Ha M3nbiiHMTen Ha o6lqecr8eha nop'b'fka 1.1pe3 ny6nm'iha nokaha, no ~ Ha rnaaa

More information

PETIYliJIHKA li'bjir APH.SI. MMHMCTepCTBO Ha 3eMe):(eJIMeTO M XpaHMTe. OliRBA

PETIYliJIHKA li'bjir APH.SI. MMHMCTepCTBO Ha 3eMe):(eJIMeTO M XpaHMTe. OliRBA PETIYliJIHKA li'bjir APH.SI MMHMCTepCTBO Ha 3eMe):(eJIMeTO M XpaHMTe OEJIACTHA )J)1PEKlJ)15I "3EME,UEJII1E" - OEmI1HCKA CJIY}KEA ITO 3EME,UEJII1E - IIJIEBEH IIJIEBEH 5800,rp.n.neaeH, y.n. "BaCV1.n neackv1"

More information

)(OrOBOP.N!! 4 I r.

)(OrOBOP.N!! 4 I r. +,cn EI~HA.III13H PAHA EiOJIHHUA 3AAKTI1BHO JI PIEHHE HA OHKOJIOfi1I.J:HI13AEiOJIHBAHIDI - CO

More information

MHCTMyYT no MNKpo6MonorMA,,CTert,aH AHr enoa" Cort,MA 1113, yn."atca,q. reoprm 60H1tea", 6n. N2 26

MHCTMyYT no MNKpo6MonorMA,,CTert,aH AHr enoa Cort,MA 1113, yn.atca,q. reoprm 60H1tea, 6n. N2 26 -------------- -- - - MHCTMyYT no MNKpo6MonorMA,,CTert,aH AHr enoa" Cort,MA 3, yn."atca,q. reoprm 60Htea", 6n. N2 26.wuKpo6uo!lo2Wl,, Cme(j)au,[(OKYMEHTAQH5 33 yq3ctue s OTKPHT3 npouellyp3 33 BhJJiar3ne

More information

PEIDEHHE. DB) 3a npo~uma DB) 3a npekpan!bahe Ha npor{e.nypa 3a Bb3JJaraHe Ha o6u {ectbcha nopbyka

PEIDEHHE. DB) 3a npo~uma DB) 3a npekpan!bahe Ha npor{e.nypa 3a Bb3JJaraHe Ha o6u {ectbcha nopbyka napnu 310 PEl UEHHE ( eepcu 41 ~ orr AfEHL.t~51 no 06~ECTBEH~ nopbyk~ 1000 Co >111!1, yn. llere 4 Q:>aKc: 940 7078 e-mail: rop@aop.bg, e-roo@aop.bg I-1HTepHeT aapec: http://www.aop.bg l lpoekt 11a peweh11e

More information

AEKJIAPAIII,I.f, fr;:nffi;::iorbparrbahe. l*... Q.. (rpure. Arrrxxocrra: rbprobcke lp5a(ecrba (uocowa ce rruero Ea rrprobckoro.

AEKJIAPAIII,I.f, fr;:nffi;::iorbparrbahe. l*... Q.. (rpure. Arrrxxocrra: rbprobcke lp5a(ecrba (uocowa ce rruero Ea rrprobckoro. Bril6ilruuM/// t flpuroneuue xru,tst. 72. r.2 AEKJIAPAIII,I.f, no sn. 12, r. 2 nrn apr:xa c,{o.ryuo4nrcauurr(u *rl i fr;:nffi;::iorbparrbahe...4/. /..y. Q.. (rpure l*... h-

More information

r-- '-- o IlpoeKT Ha pemehl'je o ) 3a npomsiha AOrr 181 PemeHHe 3a ny6julkybahe

r-- '-- o IlpoeKT Ha pemehl'je o ) 3a npomsiha AOrr 181 PemeHHe 3a ny6julkybahe napnma: 00407 PElllEHHE (1IepCHlI4) r-- AOrr '-- o IlpoeKT Ha pemehl'je 181 PemeHHe 3a ny6julkybahe HOMep: 142 OT 12/06/2015 JJJJJMM!rrrr DA) 3a OTKpHBaHe Ha npoqei\ypa o ) 3a npomsiha PEIIIEHHE 181 B)

More information

IIpHT}])Ka K'bM 0<l>HIJ,HaJIeH BeCTHHK Ha EBponeiicKHJI C'b103. OBHRnEHHE3ABD3~o»rnHAnOPbqKA

IIpHT}])Ka K'bM 0<l>HIJ,HaJIeH BeCTHHK Ha EBponeiicKHJI C'b103. OBHRnEHHE3ABD3~o»rnHAnOPbqKA napt11 na OblB.1EHHf BH_~OJl(ElA nopb4ka (aepch" 7) pht}])ka K'bM 0HJ,HaJeH BeCTHHK Ha EBponecKHJ C'b103 ::

More information

MHHHCTePCTBO Ha 3eMeJJ;eJIHeTO H XpaHHTe. OJiJIACTHA,n;:HPEKI(l:UI "3EME,lJ;EJIHE" - IIJIEBEH. CllIlC1>K

MHHHCTePCTBO Ha 3eMeJJ;eJIHeTO H XpaHHTe. OJiJIACTHA,n;:HPEKI(l:UI 3EME,lJ;EJIHE - IIJIEBEH. CllIlC1>K E _f'_ P1U MHHHCTePCTBO Ha 3eMeJJ;eJHeTO H XpaHHTe OJiJACTHA,n;:HPEK(l:U "3EME,lJ;EJHE" - JEBEH ClllC1>K Ha.ll.0nYCHaTHTe H He.ll.OnYCHaTHTe KaH.ll.H.ll.aTH ;::J;O yqactue B KOHKYPCa, 06RBeU C'bC 3arrOBe;::J;

More information

A Sound Track to Reading

A Sound Track to Reading A Sound Track to Reading Blending Flashcards Prepared by Donald L Potter June 1, 2018 Mr. Potter prepared these cards to be used with Sister Monica Foltzer s advanced intensive phonics program and reader,

More information

,11;0. OT ITPE,Il.CEM TEllii HA BbPXOBHllii KACAIJ,MOHEH Co,Il. 3A IIPI1EMAHE HA ThJIKYBATEJlliO PEIIIEHME

,11;0. OT ITPE,Il.CEM TEllii HA BbPXOBHllii KACAIJ,MOHEH Co,Il. 3A IIPI1EMAHE HA ThJIKYBATEJlliO PEIIIEHME ,11;0 OEIJ:J;OTO C'bEPAH:UE HA C'b,[QI:UTE OT HAKA3ATEJIHATA KOJIErJiUI HA B'hPXOBHIDI KACAI(IIOHEH Cp)]; H C K A H E OT ITPE,Il.CEM TEllii HA BbPXOBHllii KACAIJ,MOHEH Co,Il. 3A IIPI1EMAHE HA ThJIKYBATEJlliO

More information

npe~jjojic~tthe Ha H'.l.II'hJJJIIITEJID,, CliCTijl31'fmmrn~ CRl?T!'!l?THP.rrmwo1K~m1~ M2 N!! l, 2» 3 K1? hi~

npe~jjojic~tthe Ha H'.l.II'hJJJIIITEJID,, CliCTijl31'fmmrn~ CRl?T!'!l?THP.rrmwo1K~m1~ M2 N!! l, 2» 3 K1? hi~ I, K2 t '" ~ o, t,..,o. ~ tt..,, ~.,,t ~!. '!../... t?! f~ 'i..,'!ft~uh,,,.., r! i MI11JllGT PCTDQTO HA OT6P4HA'fA, c bg 9~J,la.n111.rn~ tt aapec: rpi CocJmff.,., l09z, y~1.!ll.{mwa H.nrnnrW 1 N~ 3., SYJrCTAT

More information

~OrOBOP. N2.(f.fi ()()fl.f?j

~OrOBOP. N2.(f.fi ()()fl.f?j EK3eMIUHlp 3a,AE~ Ko3JIO.Llyii" EA,D, ~OrOBOP N2.(f.fi ()()fl.f?j Jl.Hec, c!..f..t?.f..y;fp(e_ ro;::r;., B rp. Ko3rro;::r;yi1 Me)l(.[(y: "AEIJ, Ko3JIO,IJ.yif" EA,ll;", rp. KoJJIO,IJ.yif, BITHCaHo B TbproBCKinr

More information

Acou.nau.nH no so)l;ocua6ahba11e u KaHaJin1au.nH ua o6oco6euata TepuTopnH, o6cjiy*saua OT,,BuK" EOO,ll;-CTapfl 3aropa

Acou.nau.nH no so)l;ocua6ahba11e u KaHaJin1au.nH ua o6oco6euata TepuTopnH, o6cjiy*saua OT,,BuK EOO,ll;-CTapfl 3aropa EilYliJIHKA JibJirAPH.SI O 6 JI a c T e u 1 y n p a s u T e JI u a o 6 JI a c T C T a p a 3 a r o p a Acou.nau.nH no so)l;ocua6ahba11e u KaHaJin1au.nH ua o6oco6euata TepuTopnH, o6cjiy*saua OT,,BuK" EOO,ll;-CTapfl

More information

The Czech National Health Care Information System (NH-IS) and its strategy in building population-based reporting

The Czech National Health Care Information System (NH-IS) and its strategy in building population-based reporting The Czech National Health Care Information System (NH-IS) and its strategy in building population-based reporting Evropská unie Evropský sociální fond Operační program Zaměstnanost Regional reporting of

More information

akc: (352) Apec 3a J1KTOHH noina: HHcopMaIwI H OHnaiIH OpMyJ1MpH:

akc: (352) Apec 3a J1KTOHH noina: HHcopMaIwI H OHnaiIH OpMyJ1MpH: 17 r-i - r 2 i - flapnua: 00334 ' '... I I.A.U4I1 05BJ1EHI1E 3A flopb4ka (BepcIIV 5) ithjtu) MWCkMY.ECKO VIIPABJ1JEHgE :1EBPrIROKH. Oa!oB.x" X47. fly6iiliky4ahe Ha IIpHTypXaTaI bm k) uhaj1h BCTHHK Ha EBponeicK

More information

I Peruenue sa ny6lnxyaaue

I Peruenue sa ny6lnxyaaue napruas:00754 PEruEHUE flllpoercr Ha pelxehl4e I Peruenue sa ny6lnxyaaue Houep: 136 or 0710912015 aalrnrr,,r/rrrr Xe) sa orkphbahe Ha npolreaypa f]e) ga npomcha nb) ga npekparflbahe Ha npoqeaypa 3a Bb3JraraHe

More information

b ~ II H A K A 3 A H ]I b K

b ~ II H A K A 3 A H ]I b K " a." _. (~) 1:11 to~1 Llt ~,r i.i

More information

Declaration of conformity Adapter

Declaration of conformity Adapter Declaration of conformity acc. to VO (EG) 1935/2004 and VO (EU) 10/2011 as well as acc. to FDA Document ID: 34466 Editing status: 2017-05-19 2 CFR FDA stands for Food and Drug Administration, a U.S. authority.

More information

1\ :_:'f~~---;-f_il_~_q V\_ re_--:- ( L t-j ~~ ) s ( Jc (/6 t~--l -i~,jl..f- t:j Ll f1 ilb}.c

1\ :_:'f~~---;-f_il_~_q V\_ re_--:- ( L t-j ~~ ) s ( Jc (/6 t~--l -i~,jl..f- t:j Ll f1 ilb}.c t-=-=e.~~~t.:::_"~ :.fl...:...-c..:... 1\ :_:'f~~---;-f_il_~_q V\_ re_--:- ( L t-j ~~ ) s ( Jc (/6 t~--l -i~,jl..f- t:j Ll f1 ilb}.c c6 ~ { oo d! Lt 1e ce i v-u /-r-(j'r\-'1. 4-.z.)/ {) Pt c/o -~ ~,:u

More information

060/ r. BoJInfrsoJrEH K4yE,,MLr. /ao. OP"_fP.tIEPH[IK AOKJIAAHA 3ATIIICKA. flpularau Br43yirnr43a:g;'z,vr c pa3rlojloxehl,iero Ha pekjiamhte Lt

060/ r. BoJInfrsoJrEH K4yE,,MLr. /ao. OP_fP.tIEPH[IK AOKJIAAHA 3ATIIICKA. flpularau Br43yirnr43a:g;'z,vr c pa3rlojloxehl,iero Ha pekjiamhte Lt BoJnfrsoJrEH K4yE,,MLr OP"_fP.tEPH[K 060/ r ttl- $ t).',0- W /ao TPEACEAATEJU HA OETTWCKVTCbB fp. [E,PH4K AOKJAAHA 3ATCKA Or YC ua BK,,MuHrop" - flepuzr OTHOCHO: flocransse Ha pekrlama YBA}KAEMA OCOAH

More information

,u;orobop 3A,ll;OCTABKA HA JIEKAPCTBA. 1."MHOrOIIPO<l>HJIHA.liOJIHHIJ,A 3A AKTHBHO JIEqEHHE

,u;orobop 3A,ll;OCTABKA HA JIEKAPCTBA. 1.MHOrOIIPO<l>HJIHA.liOJIHHIJ,A 3A AKTHBHO JIEqEHHE ~"4B~.fo' "MHOfOilPOHJIHA BOJIHH~ 3AAKrHBHO JI liehhe-bypfac" rp.6yprac, n.k. 8000, 6y11."CTeaH CTa:M60110B"N173, e-mail: dirmbal@abv.bg TeJI.+359(56)810 547 +}59(56)810 592 lntertek,u;orobop 3A,ll;OCTABKA

More information

Quantitative immunochemical tests: evidence on accuracy and implementation considerations in the Czech MUDr.. Petr Kocna, CSc.

Quantitative immunochemical tests: evidence on accuracy and implementation considerations in the Czech MUDr.. Petr Kocna, CSc. Quantitative immunochemical tests: evidence on accuracy and implementation considerations in the Czech MUDr.. Petr Kocna, CSc. European Digestive Cancer Days, Prague - 26. September 2017 QUANTITATIVE FIT

More information

Temperature Dependent Infrared Cross Sections for CFC-11, CFC-12, CFC-13, CFC-14, CFC-22, CFC-113, CFC-114, and CFC-115

Temperature Dependent Infrared Cross Sections for CFC-11, CFC-12, CFC-13, CFC-14, CFC-22, CFC-113, CFC-114, and CFC-115 NCAR/TN-358+STR NCAR TECHNICAL NOTE February 1991.1 Temperature Dependent Infrared Cross Sections for CFC-11, CFC-1, CFC-13, CFC-1, CFC-, CFC-113, CFC-11, and CFC-115 S.T. Massie A. Goldman A.H. McDaniel

More information

,norobop. 3a H3D'hAHeHHe o6ulectbeba DOp'h'IKa. ,[l.hec, ro,n.., B rp.byprac, Me.)K,,Lzy:

,norobop. 3a H3D'hAHeHHe o6ulectbeba DOp'h'IKa. ,[l.hec, ro,n.., B rp.byprac, Me.)K,,Lzy: v ~i;# -t. ~.;~~ "MHOfOflPOHJHA 60J Hl,A 3A AKfHBHO JEY.EHHE-6YPfAC" AJJ. rp.6yprac, n.k. 8000, 6y."CTeq>aH CTaM60ou"~, e-mail: d irmbal@abv.bg TeJJ.+359(56)80 547 +359(56)80 592 c-~.,,,,.. '

More information

Medication Abbreviations

Medication Abbreviations ABBREVIATIONS: QUIZ 2 Medication Abbreviations 1. Which one of the following abbreviations means antidiuretic hormone? a. AH b. AD c. AIDS d. AS e. ADH 2. Which of the following abbreviations means in

More information

7th International Congress of the Spanish Society of Obesity Surgery. Valladolid Spain May, 2004.

7th International Congress of the Spanish Society of Obesity Surgery. Valladolid Spain May, 2004. 7th International Congress of the Spanish Society of Obesity Surgery. Valladolid Spain May, 2004. DIMINISHING POSTOPERATIVE RISKS OF GASTRIC BYPASS Stenosis Stenosis Leak Leak Bleeding Bleeding Stenosis

More information

(Press Release) The Results of Radioactive Material Monitoring of the Surface Water Bodies within Ibaraki Prefecture

(Press Release) The Results of Radioactive Material Monitoring of the Surface Water Bodies within Ibaraki Prefecture (P l) h l f dc Ml M f h fc W Bd h Ib Pfc Fd, Dcb 2, 2011 W E D, E M B, M f h E Dc l: 03-5521-8316 chbd: 03-3581-3351 Dc: b Yhd (x. 6610) Dp Dc: F (x. 6614) Cd: H H (x. 6628) I ccdc h h Cph d M Pl dd b

More information

«L O~~ -. L, ~ ~ /( ~:'

«L O~~ -. L, ~ ~ /( ~:' ,,l1;orobop l~i~'~~',-,'". ji:jor;j?{t. J3!31 «L O~~ -. L, ~ ~ /( ~:' AHec,... ~...~ 2017 roa., B rp. COtjnuI, Me)K)1;y: '... Ha~HOHaJlHa cnyxc.oa 3a C'LBeTH B 3CMC,n;eJlHeTO, EMK 130339616, c a.n;pec:

More information

.ao. all1pektopa Ha V1V1T - 6AH

.ao. all1pektopa Ha V1V1T - 6AH 1 8. 06. 2iJ1Q.ao all1pektopa Ha V1V1T - 6AH HHcmnrr no H" OPM. TEXHOnOfHU SAJ-f C0::l>MH., ( ax. N!!.!.....1.4..".keho BVI Vl3npaL.LtaM npenvlc~vl3ene4ehvle

More information

GSJ Geochemical Reference Samples. Igneous Rock. Sedimentary Rock. For Instrumental analysis. Reference value for environmental analysis -1

GSJ Geochemical Reference Samples. Igneous Rock. Sedimentary Rock. For Instrumental analysis. Reference value for environmental analysis -1 GSJ Geochemical Reference Samples Igneous Rock Recommended and preferable (asterisked) values (major elements in % and minor and trace elements in ppm, unless otherwise noted) N. Imai, S. Terashima, S.

More information

November 09, Information from the Bulgarian Communist Party Regarding the visit of the Secretary General of the

November 09, Information from the Bulgarian Communist Party Regarding the visit of the Secretary General of the Digital Archive International History Declassified digitalarchive.wilsoncenter.org November 09, 1982 Information from the Bulgarian Communist Party Regarding the visit of the Secretary General of the Communist

More information

How sarcoma/gist research & expert care are organized in Italy

How sarcoma/gist research & expert care are organized in Italy How sarcoma/gist research & expert care are organized in Italy Organization of care Historical migration for medical care PR VA LC VI TV BG LU GR PG CN AL MI Desi o LO PV Alzano Lombardo CO Casalpusterlen

More information

OT CbBETA HA lilipektopiite HA "CIIHllH" All, rp. CO<l>lUI

OT CbBETA HA lilipektopiite HA CIIHllH All, rp. CO<l>lUI MOTHBHPAH llokjiali OT CbBETA HA lilipektopiite HA "CIIHllH" All, rp. COlUI OTHOCHO: YCJIOBIDI H qejiecbolipa3hoct HA C,Il,EJIKH no qji 114, AJI. 1 OT 3AKOHA 3A IIYIiJIH"lfiIOTO IIPEIl:JIArAHE HA IJ.EHHH

More information

Declaration of conformity VEGAVIB 61

Declaration of conformity VEGAVIB 61 Declaration of conformity acc. to VO (EG) 1935/2004 and VO (EU) 10/2011 as well as acc. to FDA Document ID: 32556 Editing status: 2016-10-25 2 CFR FDA stands for Food and Drug Administration, a U.S. authority.

More information

ffi ll aau[h[crpr{pauero Ha MecrxrlTe rarc[ r qehrl He ycnyr[ Ha rep[topnfrra na 06u1uua I. XaparrepucrrrKa Ha ycjryrara:

ffi ll aau[h[crpr{pauero Ha MecrxrlTe rarc[ r qehrl He ycnyr[ Ha rep[topnfrra na 06u1uua I. XaparrepucrrrKa Ha ycjryrara: ffi i q )A 9. 1c, POB Ruem ua (hr4uua Cmapa jazopa BbTPEIIIHI4 IIPABI4/IA 3A I,I3IABAHE HA pa3peuehhe Cbt/tACH0 ql 32 ot 3AKOHA 3A OIIA3BAHE HA CE/TCKOCTOnAHCKOTO 14MyI{ECTB0, 34 otchqahe u T43KOPEHflBAHE

More information

OE5IBJIEHHE 3A HO LIapeKTIIBa 2004/1. Fpa& I1oWCHCKH K0JJ )Ibp)KaBa rp. Cow Periyb1J'IKa B'bJ1rapwi M5IcTo/MecTa 3a Ko1-ITaKT

OE5IBJIEHHE 3A HO LIapeKTIIBa 2004/1. Fpa& I1oWCHCKH K0JJ )Ibp)KaBa rp. Cow Periyb1J'IKa B'bJ1rapwi M5IcTo/MecTa 3a Ko1-ITaKT HapTIiza: 00334 055It3JIEIIIIE 3A FIOFI,L1KA (Hepcit$ 5) El IlpOeIcr Ha o6sibneiiue 06srnsieime 3a ny6nhicybahe EBPOHEiICKH Cb103 fly6sihkybahe Ha KbM Ojnlw'ia.neH BCTHHK Ha EBponeiicKwI Cb103 ym MepcHe

More information

-- /-f_r /te_zor 6r. IIPEACEAATEJTf, HAPOAHOTO CbEPAHTTE /"v

-- /-f_r /te_zor 6r. IIPEACEAATEJTf, HAPOAHOTO CbEPAHTTE /v IIA P() Br.No II(} CIII;tr'AII[IE nu u Ao -- /-f_r /te_zor 6r. IIPEACEAATEJTf, HAPOAHOTO CbEPAHTTE /"v T.XA IIEIIKA IIATIEBA Y ybaxaema rociioxo IPEACEAATEJT, Ha ocnosahre qjr. 8'1, a* 1 or Koscrvryr\uflTa

More information

5x2=10 1. Fill in the blanks : % fat in Buffalo (a) A minimum of % fat in Cow milk is milk and necessary for producing a desirable good

5x2=10 1. Fill in the blanks : % fat in Buffalo (a) A minimum of % fat in Cow milk is milk and necessary for producing a desirable good No. of Printed Pages : 8 DIPLOMA IN DAIRY TECHNOLOGY (DDT) Term-End Examination 00 June, 2013 CD C) BPVI-015 : DAIRY PRODUCTS - II Time : 2 hours Note : Attempt any five questions. Maximum Marks : 50 5x2=10

More information

Our next questions are about Contingency Management.

Our next questions are about Contingency Management. II.B.04.01 01 Our next questions are about Contingenc t. Higgins and Petr (1999) describe Contingenc t as the sstematic reinforcement of desired behaviors and the withholding of reinforcement or punishment

More information

InpHTYPKa K'bM O(jlHU;HaJIeH SeCTHHK lila EBpOIIeHCKIUl! CDlOa. IIH$opMaUHR H OHJIallH $OPMYJIRPH:

InpHTYPKa K'bM O(jlHU;HaJIeH SeCTHHK lila EBpOIIeHCKIUl! CDlOa. IIH$opMaUHR H OHJIallH $OPMYJIRPH: Hapnea Of,)lBJEHHL 1\ Bb JlOlKEHA nopb4ka isep"" 7) nphtypka K'bM O(jlHU;HaJeH SeCTHHK lila EBpOeHCKUl! CDlOa,:: t 'i:l *,(z * * H$opMaUHR H OHJallH $OPMYJRPH: http://simap.ted.europa.eu OBHBJEHHE 3A B'h3.JO)l{EHAnOnqKA

More information

Calypso Application. License for card and portable objects.

Calypso Application. License for card and portable objects. Calypso Application License for card and portable objects. I N N O V A T R O N CalypsoLicense page 1 / 6 Innovatron, 27 rue de Bassano, 75008 Paris, France 1. License Policy General Presentation Innovatron

More information

ALLTRADE FORKLIFT PARTS PTE LTD

ALLTRADE FORKLIFT PARTS PTE LTD ATTENTION PAGE : 1 (HALLA) FAC0300060 FAC0300080 FAC0311070 FAC0311240 FAD0300600 OK675-15-010 OK675-15-082 OS211-15-173 OS213-15-172 QK0905-15 (HANGCA) 053022 053023 198911A 36010-L9000-G00 40DH-512000

More information

(43) Publication date: 04 September 2014 ( ) (22) Filing Date: 27 February 2014 ( )

(43) Publication date: 04 September 2014 ( ) (22) Filing Date: 27 February 2014 ( ) (54) Title (EN): INCOHERENT TYPE-III MATERIALS FOR CHARGE CARRIERS CONTROL DEVICES (54) Title (FR): MATÉRIAUX DE TYPE III INCOHÉRENTS POUR DISPOSITIFS DE RÉGULATION DE PORTEURS DE CHARGES (72) Inventor(s):

More information

Barbara Pistilli Comité de Pathologie Mammaire. Vendredi 21 septembre 2018 #2018OBSERVANCE

Barbara Pistilli Comité de Pathologie Mammaire. Vendredi 21 septembre 2018 #2018OBSERVANCE FÉDÉRER LA RECHERCHE ET L INNOVATION MÉDICALE EN CANCÉROLOGIE Etat des lieux des difficultés d observance aux différents types de traitement tout au long du parcours de soin et difficulté des équipes médicales

More information

Ma lig n a n t Fibro us His tio c yto ma Orig in a tin g fro m the Che s t Wa ll

Ma lig n a n t Fibro us His tio c yto ma Orig in a tin g fro m the Che s t Wa ll * * * * * * * * ** =Abs tract= Ma lig n a n t Fibro us His tio c yto ma Orig in a tin g fro m the Che s t Wa ll Chul Burm Le e, M.D.*, Ta e Yul Chung, M.D.*, She e Young Ha lm, M.D.*, Hyuk Kim, M.D.*,

More information

DCP Networks

DCP Networks www.bps.org.uk/dcp DCP Networks To support and promote clinical psychology, working collaboratively with people who use our services and wider communities to improve wellbeing and to promote the unique

More information

LJ.EHOBO flpe)j.jlojkehhe

LJ.EHOBO flpe)j.jlojkehhe flphjiojkehhe.n'! 3 06pmetl )1.0 "CJ>AJI03- COII>H.sl OJ>JIACT" EOO)J. rp.co«jmh, oyjj."ctojjetob".n'! 67 LJ.EHOBO flpe)j.jlojkehhe 1a y tactme B OTKP I1Ta npouenypa 1a BbJJJaraHe Ha o6utectbeha nopb'

More information

OTOBOP. N./.2O17r. Co4iisi, Me)xy: 4HPKTOP a Pociva Fparopolla - HHHCOB ghpektop, napwiaa 3a KpaTKOCT

OTOBOP. N./.2O17r. Co4iisi, Me)xy: 4HPKTOP a Pociva Fparopolla - HHHCOB ghpektop, napwiaa 3a KpaTKOCT IP OTOBOP N./.2O17r. F InI Tn"nPABEH... Hec Co4iisi, Me)xy: 1. BTJIFAPCKATA HA1140HAJIHA TEJIEBH3IIH, cc cea.irnie a apec aa yripabjilehhe rp. Co4rn51, yi. "Caa CTedaHo" N2 29, c BYJICTAT 000672350, MAN

More information

"rp A)J,CKII TP AHCIIOPT" EA)], - Bapua Bapua 9000,,, yn. "Tponeiiua" 48 Te!l.: , , rpakc: e-mall.gtvarnaiioabv.

rp A)J,CKII TP AHCIIOPT EA)], - Bapua Bapua 9000,,, yn. Tponeiiua 48 Te!l.: , , rpakc: e-mall.gtvarnaiioabv. "rp A)J,CKII TP AHCIIOPT" EA)], - Bapua Bapua 9000,,, yn. "Tponeiiua" 48 Te!l.:10521572-200, 572-201, rpakc: 755-121 e-mall.gtvarnaiioabv.bg 3A YlJACTME B OEI.QECTBEHA IIOP'blJKA ljpe3 IIYEJIWUIA IIOKAHA

More information

Ml1Hl1CTEPCTBO HA OTBP AHATA HA PEIIYBJIl1KA BbJIf APl1J1,lj;l1peku;l1j1 "OTBPAHl1TEJIHA AKBl13l1U;l1J1" YCJIOBIDI

Ml1Hl1CTEPCTBO HA OTBP AHATA HA PEIIYBJIl1KA BbJIf APl1J1,lj;l1peku;l1j1 OTBPAHl1TEJIHA AKBl13l1U;l1J1 YCJIOBIDI Ml1Hl1CTEPCTBO HA OTBP AHATA HA PEIIYBJIl1KA BbJIf APl1J1,lJ;l1PEKU;l1J1 "OTBPAHl1TEJIHA AKBl13l1U;l1J1" 1092, Co

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION SUPPLEMENTRY INFORMTION doi:10.1038/nature11808 NT Phen Met ICR Oligo FCCP pmpk tmpk Supplemental figure 1. -. Primary hepatocytes were treated with 250 um Phenformin, 1 mm Metformin 250 um ICR, 100 nm

More information

Bay4ep11 3a xpaha Ha nepcoha. AOL 3a AOCTaBKa Ha 11eKapcTBeH11 noo11vkt11

Bay4ep11 3a xpaha Ha nepcoha. AOL 3a AOCTaBKa Ha 11eKapcTBeH11 noo11vkt11 .../'-,,.@3"'""'"..,o?, " -. \ -~_"''"".. { =ccl,' "- J/ ~ \ ~;l o_,.o~..,.11"11 MHOrOTIPOMJIHA 60JIHIIll,A 3A AKTHBHO JIEYEHHE " CBET A TIETKA " A.l( rp. B11)1;11H 3700, YJI. "ll,ap Cl1MEOH BEJIHKII"

More information

K 3;g =E6 $ GI#SPD7h7I: 2DDPgSX/0G* 7. (Krzpow)

K 3;g =E6 $ GI#SPD7h7I: 2DDPgSX/0G* 7. (Krzpow) %&$#$"! %&"'$"#! ³%$$$"#²!¹ )!('!&#$%!""" A:/3;?@/#$% 8&&9"2#3 45671/0,""-.,""+ : 7DE6 F+ % )> =5 B =C 3 2 7/3 GI J5 27K3L: 2 M F 1GH #T.A ;EN-57O=P5 3Q RI 7/3 % 3C 3G[,,\!-.[,]\(/0 [,( IFXZ$ #U /VWX6Y@/

More information

YBAXAEMII AAMI{ I,I TOCNOAA OEIIIUHCKI,T CbBETHI,IqII, 7700'IlproBu[re, nn. CBo6oaa Tere+oH: 0601/68 655;oaKc: 0601/63 322

YBAXAEMII AAMI{ I,I TOCNOAA OEIIIUHCKI,T CbBETHI,IqII, 7700'IlproBu[re, nn. CBo6oaa Tere+oH: 0601/68 655;oaKc: 0601/63 322 e-mai l:obs@tarsovishte.bg; www.!arcovishte.bq 7700'IlproBu[re, nn. CBo6oaa Tere+oH: 0601/68 655;oaKc: 0601/63 322 ot nllx. XarxAr(e AnleBa - npeaceaaren Ha O6u Hcxx clbet TlproBuue othocho: yrbt,pxrabahe

More information

CHAPTER 2 : CONTROL OBJECTIVES AND BENEFITS

CHAPTER 2 : CONTROL OBJECTIVES AND BENEFITS CHAPTER 2 : CONTROL OBJECTIVES AND BENEFITS When I complete this chapter, I want to be able to do the following. Recognize examples of the seven (7) control objectives in chemical processes Calculate indicators

More information

Spherical Bearings Heavy Duty Equipments

Spherical Bearings Heavy Duty Equipments Spherical Bearings Heavy Duty Equipments Highlights Quality Service Price Wbf Replacement Parts adaptableto > Caterpillar >Komatsu >Volvo 1 WBF SPHERICAL BEARINGS adaptable to Caterpillar Part No. Description

More information

Ascendens Christus in altum In Ascensione Domini

Ascendens Christus in altum In Ascensione Domini Ascendens Christus in altum In Ascensione Domini Tomàs Luis de Victoria (1572) Cantus A scen dens Chri stus in al tum, in al Quintus A scen dens Chri stus in al tum, Altus Tenor 8 A scen dens Chri stus

More information

a, Emre Sezgin a, Sevgi Özkan a, * Systems Ankara, Turkey

a, Emre Sezgin a, Sevgi Özkan a, * Systems Ankara, Turkey Available online at www.sciencedirect.com Procedia - Social and Behavioral Scien ce s 8 ( 0 ) nd World Conference on Educational Technology Researches WCETR0 The role of Gender in Pharmacists Attitudes

More information

PEilYBJIHKAbh rapidi HHCIIEKTOPAT K'bM BHCWIDI C'b,l.l.EliEH C'bBET

PEilYBJIHKAbh rapidi HHCIIEKTOPAT K'bM BHCWIDI C'b,l.l.EliEH C'bBET PEilYBJIHKAbh rapidi HHCIIEKTOPAT K'bM BHCWIDI C'b,l.l.EliEH C'bBET rp. Coqnu1 1000, yn.,,reopr BaunrnrroH" NQ 17, TeJI.q>aKc 02 989 48 66 npobepka HA HHCnEKTOPATA K'bM BHCWIDI C'b)J;EliEH C'bBET A K T

More information

)(europoss. t4dea. Q 6tnrapm, UJyueH ,. no3 t-.i,lfl, 3A KOflTO KAM'I4ATCTBATE alltxhoct. AxperIop Aero rpa,qxha,?aneh Mal( - c.

)(europoss. t4dea. Q 6tnrapm, UJyueH ,. no3 t-.i,lfl, 3A KOflTO KAM'I4ATCTBATE alltxhoct. AxperIop Aero rpa,qxha,?aneh Mal( - c. )(europoss Asro6xorpaolae Co6creexo lme. flpe3xme. OaMr4nus nhqfla,4l-loopt Al-]t4fl t4dea [4nageloBa Q 6tnrapm, UJyueH - 9700,. E A E:AaI: non xefia laara Ha pamahe, '1985 I Hal{uohanHocr 6bnrapi,{i no3

More information

BETWEEN. The lnquiries, Complaints and Reports Committee of the College of. -and-

BETWEEN. The lnquiries, Complaints and Reports Committee of the College of. -and- CPO File No. 2015-0099/2016-0120 DISCIPLINE COMMITTEE OF THE COLLEGE OF PHYSIOTHERAPISTS OF ONTARIO BETWEEN COLLEGE OF PHYSIOTHERAPISTS OF ONTARIO -and- MOHANNAD BAKRI, Registration Number 12180 NOT CE

More information

Functional Outcomes After Fracture-dislocation Of The Ankle

Functional Outcomes After Fracture-dislocation Of The Ankle Functional Outcomes After Fracture-dislocation Of The Ankle Direk Tantigate, MD, Gavin Ho, BA, Joshua Kirschenbaum, Christina E Freibott, BA, Benjamin Ascherman, BA, Justin K Greisberg, MD, J. Turner Vosseller,

More information

( ) 28 kg/ m 2, OSAHS, BMI < 24 kg/ m 2 10

( ) 28 kg/ m 2, OSAHS, BMI < 24 kg/ m 2 10 2013 9 12 5 http: / / www. cjrccm. com 435 ;, ( sleep apneahypopnea syndrome, SAHS) 20 80,, SAHS /, SAHS, [ 1 ] SAHS ( obstructive sleep apnea-hypopnea syndrome, OSAHS) OSAHS [ 2-4 ], 50% 92% OSAHS, 30%

More information

Autism Spectrum Disorders (ASD)

Autism Spectrum Disorders (ASD) Autism Spectrum Disorders (ASD) Pervasive brain developmental disorders causing severe impairment in thinking, feeling, communication, eye contact and ability to relate to others, repetitive behavior Seen

More information

RUN: 02/14/17 13:08:51 DEPARTMENT OF HEALTH AND HOSPITALS - BUREAU OF HEALTH SERVICES - FINANCING PAGE: LEGEND ------------------------------------------------------------------------------------------------------------------------------------

More information

Dementia Data Quality Toolkit. Frequently asked questions

Dementia Data Quality Toolkit. Frequently asked questions Dementia Data Quality Toolkit Frequently asked questions 3 rd October 2014 1. What is the dementia data quality toolkit? The dementia data quality toolkit incorporates system searches for EMIS Web and

More information

London, ON, Canada, London Ontario, Canada

London, ON, Canada, London Ontario, Canada P-94 THE EFFECT OF CRITICAL CARE ECHOCARDIOGRAPHY ON THE USAGE RATES OF DIAGNOSTIC ECHOCARDIOGRAPHY IN THE INTENSIVE CARE UNIT Alherbish, Aws 1 ; Priestap, Fran 1 ; Arntfield, Robert 1 1 Critical Care

More information

Nurse Initiated Sequential Compression Device Application Program for Total Knee Replacement Patient

Nurse Initiated Sequential Compression Device Application Program for Total Knee Replacement Patient Nurse Initiated Sequential Compression Device Application Program for Total Knee Replacement Patient Cheung Shuk Shan, Susana (APN,O&T, PYNEH) 15 May, 2013 Total Knee Replacement (TKR) TKR is a common

More information

Matrix Reference Materials - SCP SCIENCE

Matrix Reference Materials - SCP SCIENCE EnviroMAT SS-1 Catalogue No.: 140-025-001 EnviroMAT Contaminated Soil Lot No.: SC0063618 100 g TOTAL DIGESTION VALUES Elements Reference Value (mg/kg) Confidence Interval (mg/kg) Tolerance Interval (mg/kg)

More information

[,k t i-]5. i1\:.+lrn\t rrl r,l= and 1] 1- ilf-f kifi 1, 4. List two functions of membrane proteins.

[,k t i-]5. i1\:.+lrn\t rrl r,l= and 1] 1- ilf-f kifi 1, 4. List two functions of membrane proteins. %%{! Pre-Lab 8 DIFFUSION AND OSMOSIS Name: 1. 2. Membranes are made of The 1- ilf-f kifi 1, i1\:.+lrn\t rrl r,l= and 1] [,k t i-]5 form the bilayer of the membrane, and the are dispersed throughout the

More information

tr tr. ffti{, ,rep. sa ehepeuttnume xapakmepucmuku. br &H do.' r. Bueedeuae. Ha cepada e ekcnnoamaquf, \ / \.

tr tr. ffti{, ,rep. sa ehepeuttnume xapakmepucmuku. br &H do.' r. Bueedeuae. Ha cepada e ekcnnoamaquf, \ / \. ,rep @trptw@,wffiat a ehepettnme xapakmepcmk Ha cepada e ekcnnoamaqf, 363COoB4 br &H do.' 2.9.218r. crpar4e c n3ko Ao HynAro ioj- norpnhe na HprHn tr tr no xadacmp Beedeae Xrnlex 6nox 125, x.x Apyx6a-1,rp.

More information

.N2 Y,IJ; 15- ~.../..I.~. er f.

.N2 Y,IJ; 15- ~.../..I.~. er f. r 3ACTP AXOBATEJIEH,IJ;OrOBOP.N2 Y,IJ; 15- ~..../..I.~. er..2016 f.,ij;hec, JY.}Y.. 2016 r., Me)l(,l1Y MUHucTepcTsO H3 ot6p3h3t3 C a,l1pec: rp.cocpwi 1092, YJI ",l(5ikoh MrHamll" N2 3, EI1K 000695324,

More information

IlPOTOKOJIN!!4 no 'IJI. 57 OT IIII3OII

IlPOTOKOJIN!!4 no 'IJI. 57 OT IIII3OII 6'bJffAPCKAAKA)lEMH5I HA 1-IAYKHTE HCTHTYT no MeTa1103HaH111e, CbOpb>KeHHH III TexH011orn1,1 c UXA "AKa,q. A. 6a11escK111" U:EHT'hP no XH,LI;PO - II AEPO,IJ;HHAMIIKA - BAPHA IlPOTOKOJIN!!4 no 'IJI. 57

More information

noachnima KbM 0MHAHCOBMTE ONETH

noachnima KbM 0MHAHCOBMTE ONETH "MEI1 HHBECT X011,14HHr "AA, ap. COOHR noachnima KbM 0MHAHCOBMTE ONETH HA " MEJ1 1111BECT xonimir" AA, SP.0043151 KbM 31 iliemembpm 2017 r. (npeocmaensream Hepa3dearra qacm om Ouriaricoeunin Ingram) 1.

More information

Francesco Parlati, Ph.D.

Francesco Parlati, Ph.D. Novel Pharmacodynamic Assays to Measure Glutaminase Inhibition Following Oral Administration of CB-839 Francesco Parlati, Ph.D. Calithera Biosciences South San Francisco, California Disclosure Information

More information

Trends in injecting drug use in Europe

Trends in injecting drug use in Europe Trends in injecting drug use in Europe Linda Montanari, Bruno Guarita and Danica Thanki Annual Expert Meeting on Drug-Related Infectious Diseases Lisbon, 15-17 October Overview of the presentation 1) Information

More information

Recent Minima of 161 Eclipsing Binary Stars

Recent Minima of 161 Eclipsing Binary Stars Samolyk, JAAVSO Volume 38, 2010 85 Recent Minima of 161 Eclipsing Binary Stars Gerard Samolyk P.O. Box 20677; Greenfield, WI 53220; gsamolyk@wi.rr.com Received September 23, 2009; accepted September 25,

More information

Antithrombotics in the elderly. Robert Gabor Kiss FESC FACC Budapest

Antithrombotics in the elderly. Robert Gabor Kiss FESC FACC Budapest Antithrombotics in the elderly Robert Gabor Kiss FESC FACC Budapest The patient in the elderly You are sitting in Your office prescribing drugs and observing outcome The black box from prescription to

More information

Genetic Analysis of Allosteric Signaling in RhaR from Escherichia coli and Characterization of the VirF Protein from Shigella flexneri

Genetic Analysis of Allosteric Signaling in RhaR from Escherichia coli and Characterization of the VirF Protein from Shigella flexneri Genetic Analysis of Allosteric Signaling in RhaR from Escherichia coli and Characterization of the VirF Protein from Shigella flexneri By Bria Collette Kettle Submitted to the graduate degree program in

More information

To test the possible source of the HBV infection outside the study family, we searched the Genbank

To test the possible source of the HBV infection outside the study family, we searched the Genbank Supplementary Discussion The source of hepatitis B virus infection To test the possible source of the HBV infection outside the study family, we searched the Genbank and HBV Database (http://hbvdb.ibcp.fr),

More information

W rntroduction . Read about John Endler's experiment . Read the three possible hypotheses for guppy coloration

W rntroduction . Read about John Endler's experiment . Read the three possible hypotheses for guppy coloration Sex and the Single Guppy The purpose of this activity is to analyze how guppy populations change over time. The simulation activity allows you to start with a pool of guppies and your choice of predators,

More information

NEMA FRAME DIMENSIONS* FOOT-MOUNTED AC MACHINES

NEMA FRAME DIMENSIONS* FOOT-MOUNTED AC MACHINES 32 NEMA FRAME DIMENSIONS* FOOT-MOUNTED AC MACHIN KEYSEAT S 2F BA "H" DIA. 4 - HOL E E D V N-W U R * Dimensions in inches Frame Keyseat DIGNATION D E 2F BA H** U N-W V min R min S 42 2.62 1.75 1.69 2.06

More information

PLACE LABEL HERE BASELINE / PRE-TREATMENT. ACRIN 6657 Extension MRI Form: Baseline / Pre-Treatment MRI 1. o Unknown

PLACE LABEL HERE BASELINE / PRE-TREATMENT. ACRIN 6657 Extension MRI Form: Baseline / Pre-Treatment MRI 1. o Unknown T1 ACRIN 6657 Extension MRI Form: Baseline / Pre-Treatment MRI 1 If this is a revised or corrected form, please box. ACRIN Study 6657 No. Instructions: In accordance with the protocol, four MRI exams are

More information

Chem 4B Spring 2018 Exam 3

Chem 4B Spring 2018 Exam 3 Chem 4B Spring 2018 Exam 3 TOTAL PONTS 80 / 100 QUESTON 1 Hydrocarbon 12 pts 1.1 name and circle stereocenters 2 / 6 + 0 pts Correct cis-6-methyl-5-propylnon-3-ene + 1 pts 6-methyl + 1 pts 5-propyl + 0.5

More information

Simultaneous, rapid and sensitive quantification of 8-hydroxy-2'-deoxyguanosine and cotinine in human urine

Simultaneous, rapid and sensitive quantification of 8-hydroxy-2'-deoxyguanosine and cotinine in human urine Analytical and Bioanalytical Chemistry Electronic Supplementary Material Simultaneous, rapid and sensitive quantification of 8-hydroxy-2'-deoxyguanosine and cotinine in human urine by on-line solid-phase

More information

BULGARIAN-SWISS COOPERATION PROGRAMME 6bn1APO-WBEvlLJ,APCKA nporpama 3A Cb TPY,[1,HVILJECTBO - - -

BULGARIAN-SWISS COOPERATION PROGRAMME 6bn1APO-WBEvlLJ,APCKA nporpama 3A Cb TPY,[1,HVILJECTBO - - - BULGARIAN-SWISS COOPERATION PROGRAMME 6bn1APO-WBEvlLJ,APCKA nporpama 3A Cb TPY,[1,HVILJECTBO 0611\HHA PYCE TpHTe HMeHa, EfH, JIH'rna Kaprn.N"s, a11pec H,11

More information

BOTULISM. Shunji KOZAKI ), Tomoko KOHDA )

BOTULISM. Shunji KOZAKI ), Tomoko KOHDA ) h h h h BOTULISM Shunji KOZAKI ), Tomoko KOHDA ) and Kaoru UMEDA ) ) Department of Veterinary Science, Graduate School of Life and Environmental Sciences, Osaka Prefecture University, 1h58 Rinku-Orai-Kita,

More information